PLUS THERAPEUTICS, INC.·4

Feb 17, 4:30 PM ET

LaFrance Norman D. 4

4 · PLUS THERAPEUTICS, INC. · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
LaFrance Norman D.
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-15+74,98174,981 total
    Exercise: $0.39Exp: 2033-02-15Common Stock (74,981 underlying)
Footnotes (1)
  • [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION